• 1
    Vakil N, van Zanten SV, Kahrilas P et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 190020.
    Direct Link:
  • 2
    Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54: 7107.
  • 3
    Ronkainen J, Aro P, Storskrubb T et al. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population – the Kalixanda study. Aliment Pharmacol Ther 2006; 23: 172533.
  • 4
    Gisbert JP, Cooper A, Karagiannis D et al. Impact of gastroesophageal reflux disease on patients’ daily lives: a European observational study in the primary care setting. Health Qual Life Outcomes 2009; 7: 60.
  • 5
    Toghanian S, Wahlqvist P, Johnson DA et al. The burden of disrupting gastro-oesophageal reflux disease: a database study in US and European cohorts. Clin Drug Investig 2010; 30: 16778.
  • 6
    Gisbert JP, Cooper A, Karagiannis D et al. Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study. Health Qual Life Outcomes 2009; 7: 90.
  • 7
    Jones R, Liker HR, Ducrotté P. Relationship between symptoms, subjective well-being and medication use in gastro-oesophageal reflux disease. Int J Clin Pract 2007; 61: 13017.
  • 8
    Hungin AP, Hill C, Raghunath A. Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia. Aliment Pharmacol Ther 2009; 30: 33142.
  • 9
    Liker HR, Ducrotté P, Malfertheiner P. Unmet medical needs among patients with gastroesophageal reflux disease: a foundation for improving management in primary care. Dig Dis 2009; 27: 627.
  • 10
    Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease – where next? Aliment Pharmacol Ther 2005; 22: 7994.
  • 11
    Gisbert JP, Cooper A, Karagiannis D et al. Management of gastro-oesophageal reflux disease in primary care: a European observational study. Curr Med Res Opin 2009; 25: 277784.
  • 12
    Baldi F, Crotta S, Penagini R. Guidelines for the diagnostic and therapeutic management of patients with gastro-oesophageal reflux disease. A position statement of The Italian Association of Hospital Gastroenterologists (AIGO), Italian Society of Gastrointestinal Endoscopy (SIED), and Italian Society of Gastroenterology (SIGE). Ital J Gastroenterol Hepatol 1998; 30: 10712.
  • 13
    Katelaris P, Holloway R, Talley N et al. Gastro-oesophageal reflux disease in adults: guidelines for clinicians. J Gastroenterol Hepatol 2002; 17: 82533.
  • 14
    Moraes-Filho J, Cecconello I, Gama-Rodrigues J et al. Brazilian consensus on gastroesophageal reflux disease: proposals for assessment, classification, and management. Am J Gastroenterol 2002; 97: 2418.
    Direct Link:
  • 15
    Armstrong D, Marshall JK, Chiba N et al. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults – update 2004. Can J Gastroenterol 2005; 19: 1535.
  • 16
    Koop H, Schepp W, Muller-Lissner S et al. Consensus conference of the DGVS on gastroesophageal reflux [in German]. Z Gastroenterol 2005; 43: 1634.
  • 17
    Marzo M, Carrillo R, Mascort JJ et al. Management of patients with GERD. Clinical practice guideline. 2008 update. Clinical Practice Guideline Working Group on GERD [in Spanish]. Gastroenterol Hepatol 2009; 32: 43164.
  • 18
    Davis DA, Taylor-Vaisey A. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. Can Med Assoc J 1997; 157: 40816.
  • 19
    James PA, Cowan TM, Graham RP, Majeroni BA. Family physicians’ attitudes about and use of clinical practice guidelines. J Fam Pract 1997; 45: 3417.
  • 20
    Grol R. Successes and failures in the implementation of evidence-based guidelines for clinical practice. Med Care 2001; 39: II4654.
  • 21
    Wright J, Warren E, Reeves J et al. Effectiveness of multifaceted implementation of guidelines in primary care. J Health Serv Res Policy 2003; 8: 1428.
  • 22
    Grimshaw JM, Thomas RE, MacLennan G et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004; 8: iiiiv, 1-72.
  • 23
    Ponce J, Garrigues V, Agréus L et al. Structured management strategy versus usual care for gastroesophageal reflux disease: rationale for pooled analysis of five European cluster-randomized trials. Therap Adv Gastroenterol 2011; 4: 1126.
  • 24
    Jones R, Junghard O, Dent J et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther 2009; 30: 10308.
  • 25
    Jones R, Coyne K, Wiklund I. The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care. Aliment Pharmacol Ther 2007; 25: 14519.
  • 26
    Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998; 7: 7583.
  • 27
    Shaw M, Dent J, Beebe T et al. The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials. Health Qual Life Outcomes 2008; 6: 31.
  • 28
    Dean BB, Gano ADJ, Knight K et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004; 2: 65664.
  • 29
    Fass R. Functional heartburn: what it is and how to treat it. Gastrointest Endosc Clin N Am 2009; 19: 2333.
  • 30
    Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut 2009; 58: 295309.
  • 31
    Mearin F, Ponce J, Ponce M et al. Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 2012; 24: 66574.